Phase 1 Dose- Escalation Trial of Clofarabine Followed by Escalating Dose of Fractionated Cyclophosphamide in Adults with Relapsed or Refractory Acute Leukaemias

The prognosis of patients with relapsed and refractory acute leukaemia (RRAL) is very poor. Forty patients with RRAL were enrolled (28 acute myeloid leukaemia [AML], 12 acute lymphoblastic leukaemia [ALL]) in this Phase 1 dose-escalation trial of daily-infused clofarabine (CLO) followed by cyclophos...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Zeidan, Amer M, Ricklis, Rebecca M, Carraway, Hetty E, Yun, Hyun D, Greer, Jacqueline M, Smith, B Douglas, Levis, Mark J, McDevitt, Michael A, Pratz, Keith W, Showel, Margaret M, Gladstone, Douglas E, Gore, Steven D, Karp, Judith E
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2012
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3389586/
https://ncbi.nlm.nih.gov/pubmed/22594769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1365-2141.2012.09142.x
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak